XeNA: capecitabine plus docetaxel, with or without trastuzumab, as preoperative therapy for early breast cancer. [electronic resource]
Producer: 20090227Description: 341-6 p. digitalISSN:- 1449-1907
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Capecitabine
- Deoxycytidine -- analogs & derivatives
- Docetaxel
- Female
- Fluorouracil -- analogs & derivatives
- Humans
- Immunotherapy
- Middle Aged
- Neoadjuvant Therapy
- Preoperative Care
- Taxoids -- therapeutic use
- Trastuzumab
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.